References
- Jassal SV, Devins GM, Chan CT, et al. Improvements in cognition in patients converting from thrice weekly hemodialysis to nocturnal hemodialysis: a longitudinal pilot study. Kidney Int. 2006;70:956–962.
- Kurella M, Mapes DL, Port FK, et al. Correlates and outcomes of dementia among dialysis patients: the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2006;21:2543–2548.
- Kurella M, Chertow GM, Fried LF, et al. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol. 2005;16:3127–3133.
- Kurella-Tamura M, Wadley V, Yaffe K, et al. Kidney function and cognitive impairment in US adults: the REGARDS (Reasons for Gegraphic and Racial Differences in Stroke) study. Am J Kidney Dis. 2008;52:227–234.
- Elias MF, Elias PK, Seliger SL, et al. Chronic kidney disease, creatinine and cognitive functioning. Nephrol Dial Transplant. 2009;24:2446–2452.
- Seliger SL, Gillen DL, Longstreth WT, et al. Elevated risk of stroke among patients with end-stage renal disease. Kidney Int. 2003;64:603–609.
- Royal DR, Cordes JA, Polk M. CLOX: an executive clock drawing task. J Neurol Neurosurg Psychiatry. 2006;64:588–594.
- Wahlund LO, Barkhof F, Fazekas F, et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32:1318–1322.
- Furuta A, Ishii N, Nishibara Y, et al. Medullary arteries in aging and dementia. Stroke. 1991;22:442–446.
- Roman GC, Erkinjuntti T, Wallin A, et al. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002;1:426–436.
- Ringelstein E, Nabavi DG. Cerebral small vessel disease: cerebral microangiopathies. Curr Opin Neurol. 2005;18:179–188.
- Uspenskaia O, Liebertrau M, Herms J, et al. Aging is associated with increased collagen type IV accumulation in the basal lamina of human cerebral microvessels. BMC Neurosci. 2004;5:37 doi:10.1186/1471-2202-5-37.
- Integan HD, Deng LY, Li JS, et al. Mechanics and composition of human subcutaneous resistance arteries in essential hypertension. Hypertension. 1999;33:569–574.
- Flamant M, Placier S, Dubroca C, et al. Role of matrix metalloproteinases in early hypertensive vascular remodeling. Hypertension. 2007;50:212. doi:10.1161/HYPERTENSIONAHA.107.089631.
- Tsilibary EC. Microvascular bassement membrane in diabetes mellitus. J Pathol. 2003;200:537–546.
- Liebetrau M, Burggraf D, Büscher C, et al. Ramipril prevents extracellular matrix accumulation in cerebral microvessels. Neurol Res. 2005;27:477–482.
- Rizzoni D, Porteri E, De Ciuceis C, et al. Effect of treatment with Candesartan or Enalapril on subcutaneous small artery structure in hypertensive patients with noninsulin-dependent diabetes mellitus. Hypertension. 2005;45:659–665.
- Tsukuda K, Mogi M, Li JM, et al. Amelioration of cognitive impairment in the type 2 diabetic mouse by the angiotensin II type 1 receptor blocker candesartan. Hypertension. 2007;50:1099–1105.
- Seliger SL, Longstreth WT. Lessons about brain vascular disease from another pulsating organ, the kidney. Stroke. 2008;39:5–6.